Novartis investigative site

Edmonton

0 studies enrolling now · 5 studies all time

What they study most

Alzheimer Disease, Chronic Myeloid Leukemia, Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy, Non-Small Cell Lung Cancer, Pulmonary Arterial Hypertension

Studies at this site

• A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer — Stopped early
• Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis — Completed
• Imatinib (QTI571) in Pulmonary Arterial Hypertension — Completed
• Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline — Completed
• Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia — NO_LONGER_AVAILABLE